My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

2.800 -0.050 (-1.75%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cabaletta Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday ↗

September 05, 2023

U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Analyst Ratings for Cabaletta Bio ↗

September 05, 2023

Via Benzinga

The 7 Most Promising Momentum Stocks to Own Now ↗

August 31, 2023

These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility.

Via InvestorPlace

HC Wainwright & Co. Maintains Buy Rating for Cabaletta Bio: Here's What You Need To Know ↗

August 11, 2023

Via Benzinga

Why Shares of Cabaletta Bio Are Up Tuesday ↗

July 18, 2023

The biotech stock rose after an analyst upgrade.

Via The Motley Fool

Recap: Cabaletta Bio Q1 Earnings ↗

May 11, 2023

Via Benzinga

Where Cabaletta Bio Stands With Analysts ↗

April 03, 2023

Via Benzinga

Where Cabaletta Bio Stands With Analysts ↗

March 17, 2023

Via Benzinga

Analyst Sees Positive Outlook For Cabaletta Bio: Sees Promise In CAR-T Therapy Approach ↗

July 18, 2023

Guggenheim Securities initiated coverage of Cabaletta Bio Inc (NASDAQ: CABA) with a Buy rating and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023 ↗

July 18, 2023

Via Benzinga

SPOT Stock Alert: Spotify Moves on Analyst Upgrade ↗

June 21, 2023

Spotify (SPOT) stock is moving on Wednesday following an upgrade and price target from Wolfe Research analyst Zach Morrissey.

Via InvestorPlace

Why Is Cabaletta Bio (CABA) Stock Down 8% Today? ↗

June 21, 2023

Cabaletta Bio (CABA) stock is falling on Wednesday following news of insider selling at the targeted cell therapy company.

Via InvestorPlace

Why Advanced Health Intelligence Shares Are Trading Higher By 111%; Here Are 20 Stocks Moving Premarket ↗

June 21, 2023

Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares gained 110.8% to $1.56 in pre-market trading after the company signed a Letter of Intention with UAE-Based e-script medicine management...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 21, 2023

It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Wednesday morning!

Via InvestorPlace

La-Z-Boy, FedEx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 21, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. Zura Bio Limited (NASDAQ: ZURA) shares tumbled 7.7% to $11.82 in...

Via Benzinga

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 16, 2023

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.

Via Benzinga

Stratasys, Navitas Semiconductor, United Insurance And Other Big Stocks Moving Higher On Tuesday ↗

May 16, 2023

U.S. stocks traded mostly lower, with the Dow Jones dropping around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 31, 2023

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.

Via Benzinga

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗

January 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 20, 2023

Via Benzinga

Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

December 23, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 23, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 08, 2022

Via Benzinga

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 14, 2022

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 14, 2022

Gainers

Via Benzinga

Why MorphoSys Shares Are Trading Lower By Around 32%; Here Are 30 Stocks Moving Premarket ↗

November 14, 2022

Via Benzinga

Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock ↗

November 11, 2022

One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 07, 2022

Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.